Ignace Demeyer - Concepedia

Concepedia

Author

Ignace Demeyer

Onze Lieve Vrouwziekenhuis Hospital ORCID

Also Known As

Demeyer I, I Demeyer, I. Demeyer, Ignace DeMeyer, Ignace Demeyer

24

Publications

4.4K

Citations

14

H-Index

37

Concepts

All Affiliations

Onze Lieve Vrouwziekenhuis Hospital Ghent University Hospital Hadassah Medical Center University of Colorado Denver

ID

About

Ignace Demeyer is an author at Onze Lieve Vrouwziekenhuis Hospital specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	1K
2	Anesthesia	2	2	83
3	Health Sciences	1	1	14
4	Natural Sciences	1	1	17
5	Chemistry	1	1	17

Ignace Demeyer

×

16

Publications

4.4K

Citations

14

H-Index

	Year	Citations
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by <i>Staphylococcus aureus</i> Vance G. Fowler, Helen W. Boucher, G. Ralph Corey, New England Journal of Medicine	2006	1.5K
Efficacy and Safety of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) in Severe Sepsis Edward Abraham, Konrad Reinhart, Steven M. Opal, JAMA	2003	951
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial Ernst-Rüdiger Kuse, Ploenchan Chetchotisakd, Clóvis Arns da Cunha, The Lancet Invasive CandidosisAntifungal AgentAntifungal AgentsMedicinePhase Iii	2007	689
A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis* Todd W. Rice, Arthur P. Wheeler, Gordon R. Bernard, Critical Care Medicine	2010	479
Effective Reversal of Moderate Rocuronium- or Vecuronium-induced Neuromuscular Block with Sugammadex, a Selective Relaxant Binding Agent Koen Suy, Karl Morias, Guy Cammu, Anesthesiology	2007	204
Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial* Steven M. Opal, Pierre‐François Laterre, Edward Abraham, Critical Care Medicine	2004	145
Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers Guy Cammu, Pieter‐Jan de Kam, Ignace Demeyer, British Journal of Anaesthesia Drug SafetyPharmaceutical ScienceHealthy VolunteersPharmacologyClinical Pharmacology	2008	96
Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose–response relationship F. Pühringer, Mae O. Gordon, Ignace Demeyer, British Journal of Anaesthesia Sevoflurane AnaesthesiaMedicineNeuromuscular BlockadePharmacotherapyAnesthesia	2010	70
Monitoring of herpes simplex virus in the lower respiratory tract of critically ill patients using real-time PCR: a prospective study Nathalie De Vos, Lieve Van Hoovels, Anne Vankeerberghen, Clinical Microbiology and Infection Diagnostic VirologyViral DiagnosticsReal-time PcrHerpes Simplex VirusPatient Safety	2009	68
Dialysability of sugammadex and its complex with rocuronium in intensive care patients with severe renal impairment Guy Cammu, Bruno Van Vlem, Michel M. van den Heuvel, British Journal of Anaesthesia Severe Renal ImpairmentUrologyMedicineKidney FailureChronic Kidney Disease	2012	65

Page 1